IP-10 is critical for effector T cell trafficking and host survival in Toxoplasma gondii infection

被引:261
作者
Khan, IA
MacLean, JA
Lee, FS
Casciotti, L
DeHaan, E
Schwartzman, JD
Luster, AD [1 ]
机构
[1] Harvard Univ, Massachusetts Gen Hosp, AIDS Res Ctr, Sch Med,Allergy & Immunol Unit,Infect Dis Unit, Boston, MA 02114 USA
[2] Dartmouth Med Ctr, Dept Med, Hanover, NH 03755 USA
[3] Dartmouth Med Ctr, Dept Pathol, Hanover, NH 03755 USA
关键词
D O I
10.1016/S1074-7613(00)80200-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The generation of an adaptive immune response against intracellular pathogens requires the recruitment of effector T cells to sites of infection. Here we show that the chemokine IP-10, a specific chemoattractant for activated T cells, controls this process in mice naturally infected with Toxoplasma gondii. Neutralization of IP-10 in infected mice inhibited the massive influx of T cells into tissues and impaired antigen-specific T cell effector functions. This resulted in >1000-fold increase in tissue parasite burden and a marked increase in mortality compared to control antibody-treated mice. These observations suggest that IP-10 may play a broader role in the localization and function of effector T cells at sites of Th1 inflammation.
引用
收藏
页码:483 / 494
页数:12
相关论文
共 48 条
  • [21] DETECTION OF A GAMMA-INTERFERON-INDUCED PROTEIN IP-10 IN PSORIATIC PLAQUES
    GOTTLIEB, AB
    LUSTER, AD
    POSNETT, DN
    CARTER, DM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 168 (03) : 941 - 948
  • [22] Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization
    Gunn, MD
    Kyuwa, S
    Tam, C
    Kakiuchi, T
    Matsuzawa, A
    Williams, LT
    Nakano, H
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (03) : 451 - 460
  • [23] HAKIM FT, 1991, J IMMUNOL, V147, P2310
  • [24] INDUCTION OF CD4(+) AND CD8(+) T-CELL RESPONSES IN EFFERENT LYMPH RESPONDING TO TOXOPLASMA-GONDII INFECTION - ANALYSIS OF PHENOTYPE AND FUNCTION
    INNES, EA
    PANTON, WRM
    SANDERSON, A
    THOMSON, KM
    WASTLING, JM
    MALEY, S
    BUXTON, D
    [J]. PARASITE IMMUNOLOGY, 1995, 17 (03) : 151 - 160
  • [25] SCID MOUSE MODELS OF ACUTE AND RELAPSING CHRONIC TOXOPLASMA-GONDII INFECTIONS
    JOHNSON, LL
    [J]. INFECTION AND IMMUNITY, 1992, 60 (09) : 3719 - 3724
  • [26] KHAN IA, 1991, J IMMUNOL, V147, P3501
  • [27] Khan IA, 1996, J IMMUNOL, V157, P2103
  • [28] INDUCTION OF ANTIGEN-SPECIFIC HUMAN CYTOTOXIC T-CELLS BY TOXOPLASMA-GONDII
    KHAN, IA
    SMITH, KA
    KASPER, LH
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (06) : 1879 - 1886
  • [29] KHAN IA, 1994, J IMMUNOL, V152, P1856
  • [30] Measurement of the efficacy of vaccines and antimicrobial therapy against infection with Toxoplasma gondii
    Kirisits, MJ
    Mui, E
    McLeod, R
    [J]. INTERNATIONAL JOURNAL FOR PARASITOLOGY, 2000, 30 (02) : 149 - 155